A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants with Severe Asthma who Completed the VALIANT Trial. (UPB-CP-05)

Principal Investigator

Dr Rob Hallifax

Contact us

Email: emcrf@ouh.nhs.uk

IRAS number

1011475